Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | GAA | P10253 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | RHOC | P08134 | 1/20 | 0.44 |
| ▸ | RHOA | P61586 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | GFER | P55789 | 1/20 | 0.44 |
| ▸ | DRD2 | P14416 | 1/20 | 0.44 |
| ▸ | DRD4 | P21917 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11528235 | 0.90 | MAPT (0.58) | MAPTMEN1KMT2ALMNAALDH1A1 | |
| SCHEMBL11526668 | 0.88 | MAPT (0.77) | MAPTMEN1KMT2AGAALMNA | |
| SCHEMBL1947326 | 0.87 | MEN1 (0.47) | MAPTMEN1KMT2AGAALMNA | |
| SCHEMBL3029679 | 0.87 | MEN1 (0.47) | MAPTMEN1KMT2AGAALMNA | |
| SCHEMBL21242322 | 0.86 | MAPT (0.43) | MAPTMEN1KMT2AGAALMNA | |
| SCHEMBL11348193 | 0.86 | STK17A (0.55) | MAPTMEN1KMT2AALDH1A1RHOC | |
| SCHEMBL656024 | 0.85 | STK17A (0.50) | MAPTMEN1KMT2AGAACYP1A2 | |
| SCHEMBL4155501 | 0.85 | MEN1 (0.46) | MAPTMEN1KMT2AGAAALDH1A1 | |
| SCHEMBL1801536 | 0.85 | NR1I2 (0.56) | MAPTMEN1KMT2AGAALMNA | |
| SCHEMBL296404 | 0.85 | HPGD (0.46) | MAPTMEN1KMT2AGAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170368015-A1 | NOVEL COMPOUND AND ANTIVIRAL AGENT CONTAINING SAME AS ACTIVE INGREDIENT | NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY (JP) | 2017-12-28 | — | — | US | claimed |
| US-20170368015-A1 | NOVEL COMPOUND AND ANTIVIRAL AGENT CONTAINING SAME AS ACTIVE INGREDIENT | NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY (JP) | 2017-12-28 | — | — | US | disclosed |
| EP-0280373-B1 | PROCESS FOR THE DIMERIZATION OF OLEFINS | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1992-08-12 | — | — | EP | disclosed |
| US-4859646-A | Process for the dimerization of olefins | SHELL OIL COMPANY (US) | 1989-08-22 | — | — | US | disclosed |
| US-4806647-A | PALLADIUM(II) COMPOUND, CHELATE LIGAND, PROTONIC ACID AND SALT | SHELL OIL COMPANY (US) | 1989-02-21 | — | — | US | disclosed |
| EP-0170311-B1 | PROCESS FOR THE DIMERIZATION OF OLEFINS | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1989-02-01 | — | — | EP | disclosed |
| US-4692548-A | DIMERIZATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | SHELL OIL COMPANY (US) | 1987-09-08 | — | — | US | disclosed |
| US-4634793-A | PALLADIUM CATALYST SYSTEM | SHELL OIL COMPANY (US) | 1987-01-06 | — | — | US | disclosed |
| EP-0206367-A2 | Process for the dimerization of ethylenically unsaturated compounds | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1986-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170368015-A1 | NOVEL COMPOUND AND ANTIVIRAL AGENT CONTAINING SAME AS ACTIVE INGREDIENT | SARS1, ZC3HAV1, ZC3HAV1L | MAPT 4702/4885MEN1 4555/4885KMT2A 3615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.